149 related articles for article (PubMed ID: 30139026)
1. [Establishment of Cas9 stably expressed human hepatocellular carcinoma and cholangiocarcinoma cell lines].
Zuo CX; Bian XC; Yang ZL; Feng HL; Zhou FY; Liu YQ
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):572-579. PubMed ID: 30139026
[No Abstract] [Full Text] [Related]
2. [Establishment and validation of human cancer cell lines with stable Cas9 expression].
Bian XC; Yang ZL; Feng HL; Zhao XM; Gu B; Li J; Sun H; Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):43-48. PubMed ID: 28072976
[No Abstract] [Full Text] [Related]
3. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
Peng Y; Yang T; Tang X; Chen F; Wang S
Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
[TBL] [Abstract][Full Text] [Related]
4. Construction of Traf3 knockout liver cancer cell line using CRISPR/Cas9 system.
Hu W; Guo G; Chi Y; Li F
J Cell Biochem; 2019 Sep; 120(9):14908-14915. PubMed ID: 31016787
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus Vectors Expressing Eight Multiplex Guide RNAs of CRISPR/Cas9 Efficiently Disrupted Diverse Hepatitis B Virus Gene Derived from Heterogeneous Patient.
Kato Y; Tabata H; Sato K; Nakamura M; Saito I; Nakanishi T
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638909
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
[TBL] [Abstract][Full Text] [Related]
8. Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites.
Nasir A; Lehrke HD; Mounajjed T; Said S; Zhang L; Yasir S; Shah SS; Chandan VS; Smyrk TC; Moreira RK; Boland Froemming JM; Herrera Hernandez LP; Wu TT; Graham RP
Am J Clin Pathol; 2019 Jul; 152(2):190-199. PubMed ID: 31107526
[TBL] [Abstract][Full Text] [Related]
9. Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.
Ryø LB; Thomsen EA; Mikkelsen JG
Methods Mol Biol; 2019; 1961():93-109. PubMed ID: 30912042
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CD133+ parenchymal cells in the liver: histology and culture.
Yoshikawa S; Zen Y; Fujii T; Sato Y; Ohta T; Aoyagi Y; Nakanuma Y
World J Gastroenterol; 2009 Oct; 15(39):4896-906. PubMed ID: 19842219
[TBL] [Abstract][Full Text] [Related]
11. An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue.
Jin J; Xu Y; Huo L; Ma L; Scott AW; Pizzi MP; Li Y; Wang Y; Yao X; Song S; Ajani JA
PLoS One; 2020; 15(2):e0228910. PubMed ID: 32053639
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
13. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
[TBL] [Abstract][Full Text] [Related]
14. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
Sugano SS; Nishihama R
Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
[TBL] [Abstract][Full Text] [Related]
16. A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines.
Wardyn JD; Chan ASY; Jeyasekharan AD
Curr Protoc; 2021 Nov; 1(11):e286. PubMed ID: 34748280
[TBL] [Abstract][Full Text] [Related]
17. Development of a Bicistronic Vector for the Expression of a CRISPR/Cas9-mCherry System in Fish Cell Lines.
Escobar-Aguirre S; Arancibia D; Escorza A; Bravo C; Andrés ME; Zamorano P; Martínez V
Cells; 2019 Jan; 8(1):. PubMed ID: 30669572
[TBL] [Abstract][Full Text] [Related]
18. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
[TBL] [Abstract][Full Text] [Related]
19. Cas9 gRNA engineering for genome editing, activation and repression.
Kiani S; Chavez A; Tuttle M; Hall RN; Chari R; Ter-Ovanesyan D; Qian J; Pruitt BW; Beal J; Vora S; Buchthal J; Kowal EJ; Ebrahimkhani MR; Collins JJ; Weiss R; Church G
Nat Methods; 2015 Nov; 12(11):1051-4. PubMed ID: 26344044
[TBL] [Abstract][Full Text] [Related]
20. [A case of hepatocellular-cholangiocarcinoma invading the gallbladder].
Namkoong KY; Kang MJ; Im HM; Kim MS; Ko BS; Ahn HT; Lee JR; Kim JO
Korean J Hepatol; 2004 Jun; 10(2):148-53. PubMed ID: 15218349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
